Kyle Mikson CFA
Stock Analyst at Canaccord Genuity
(4.13)
# 1,571
Out of 4,574 analysts
434
Total ratings
40.1%
Success rate
7.8%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGEN Repligen | Reiterated: Hold | $145 | $131.96 | +9.88% | 11 | Jul 23, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $80 | $42.69 | +87.40% | 10 | Jul 20, 2026 | |
| LON: ONT Oxford Nanopore Technologies plc | Reiterated: Buy | 200p → 180p | 108p | +66.98% | 10 | Jul 14, 2026 | |
| ILMN Illumina | Rated: Hold | $140 → $190 | $194.09 | -2.11% | 49 | Jul 13, 2026 | |
| VCYT Veracyte | Rated: Hold | $42 → $60 | $56.61 | +5.99% | 11 | Jul 13, 2026 | |
| NTRA Natera | Rated: Buy | $285 → $330 | $261.99 | +25.96% | 36 | Jul 13, 2026 | |
| GH Guardant Health | Rated: Buy | $135 → $205 | $147.33 | +39.14% | 40 | Jul 13, 2026 | |
| TWST Twist Bioscience | Rated: Buy | $90 → $120 | $90.27 | +32.93% | 2 | Jul 13, 2026 | |
| TXG 10x Genomics | Rated: Buy | $32 → $50 | $46.27 | +8.06% | 29 | Jul 13, 2026 | |
| SEER Seer, Inc. | Maintained: Buy | $4 | $1.97 | +103.05% | 3 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 | $15.52 | +41.75% | 8 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $266 | $19.66 | +1,254.98% | 1 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $27 | $22.00 | +22.73% | 27 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $67.84 | +17.92% | 14 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $3.67 | +8.99% | 30 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.9076 | +230.54% | 19 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $4.68 | +70.94% | 25 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.36 | +120.59% | 33 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.7701 | +29.85% | 22 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $24.69 | +62.04% | 26 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $75 | $59.10 | +26.90% | 10 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $5 | $0.0002 | n/a | 12 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $15 | $15.97 | n/a | 3 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $4.74 | n/a | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.00 | n/a | 1 | Mar 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.38055 | n/a | 1 | Jan 28, 2021 |
Repligen
Jul 23, 2026
Reiterated: Hold
Price Target: $145
Current: $131.96
Upside: +9.88%
Tempus AI
Jul 20, 2026
Reiterated: Buy
Price Target: $80
Current: $42.69
Upside: +87.40%
Oxford Nanopore Technologies plc
Jul 14, 2026
Reiterated: Buy
Price Target: 200p → 180p
Current: 108p
Upside: +66.98%
Illumina
Jul 13, 2026
Rated: Hold
Price Target: $140 → $190
Current: $194.09
Upside: -2.11%
Veracyte
Jul 13, 2026
Rated: Hold
Price Target: $42 → $60
Current: $56.61
Upside: +5.99%
Natera
Jul 13, 2026
Rated: Buy
Price Target: $285 → $330
Current: $261.99
Upside: +25.96%
Guardant Health
Jul 13, 2026
Rated: Buy
Price Target: $135 → $205
Current: $147.33
Upside: +39.14%
Twist Bioscience
Jul 13, 2026
Rated: Buy
Price Target: $90 → $120
Current: $90.27
Upside: +32.93%
10x Genomics
Jul 13, 2026
Rated: Buy
Price Target: $32 → $50
Current: $46.27
Upside: +8.06%
Seer, Inc.
Jul 6, 2026
Maintained: Buy
Price Target: $4
Current: $1.97
Upside: +103.05%
Jul 2, 2026
Reiterated: Hold
Price Target: $22
Current: $15.52
Upside: +41.75%
Jun 18, 2026
Reiterated: Buy
Price Target: $266
Current: $19.66
Upside: +1,254.98%
Jun 18, 2026
Reiterated: Buy
Price Target: $22 → $27
Current: $22.00
Upside: +22.73%
Jun 1, 2026
Reiterated: Buy
Price Target: $80
Current: $67.84
Upside: +17.92%
May 27, 2026
Maintained: Hold
Price Target: $4
Current: $3.67
Upside: +8.99%
May 15, 2026
Reiterated: Buy
Price Target: $3
Current: $0.9076
Upside: +230.54%
May 11, 2026
Maintained: Buy
Price Target: $8
Current: $4.68
Upside: +70.94%
May 8, 2026
Reiterated: Buy
Price Target: $3
Current: $1.36
Upside: +120.59%
May 8, 2026
Maintained: Hold
Price Target: $1
Current: $0.7701
Upside: +29.85%
May 6, 2026
Maintained: Buy
Price Target: $40
Current: $24.69
Upside: +62.04%
May 5, 2026
Reiterated: Buy
Price Target: $100 → $75
Current: $59.10
Upside: +26.90%
Jul 29, 2024
Maintained: Hold
Price Target: $3 → $5
Current: $0.0002
Upside: n/a
Jun 1, 2021
Maintained: Buy
Price Target: $13 → $15
Current: $15.97
Upside: n/a
Mar 29, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $4.74
Upside: n/a
Mar 9, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $1.00
Upside: n/a
Jan 28, 2021
Initiated Coverage: Buy
Price Target: $10
Current: $0.38055
Upside: n/a